Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin - PubMed (original) (raw)
Review
Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin
B D Spangler. Microbiol Rev. 1992 Dec.
Abstract
Cholera and the related Escherichia coli-associated diarrheal disease are important problems confronting Third World nations and any area where water supplies can become contaminated. The disease is extremely debilitating and may be fatal in the absence of treatment. Symptoms are caused by the action of cholera toxin, secreted by the bacterium Vibrio cholerae, or by a closely related heat-labile enterotoxin, produced by Escherichia coli, that causes a milder, more common traveler's diarrhea. Both toxins bind receptors in intestinal epithelial cells and insert an enzymatic subunit that modifies a G protein associated with the adenylate cyclase complex. The consequent stimulated production of cyclic AMP, or other factors such as increased synthesis of prostaglandins by intoxicated cells, initiates a metabolic cascade that results in the excessive secretion of fluid and electrolytes characteristic of the disease. The toxins have a very high degree of structural and functional homology and may be evolutionarily related. Several effective new vaccine formulations have been developed and tested, and a growing family of endogenous cofactors is being discovered in eukaryotic cells. The recent elucidation of the three-dimensional structure of the heat-labile enterotoxin has provided an opportunity to examine and compare the correlations between structure and function of the two toxins. This information may improve our understanding of the disease process itself, as well as illuminate the role of the toxin in studies of signal transduction and G-protein function.
Similar articles
- Structural biology and structure-based inhibitor design of cholera toxin and heat-labile enterotoxin.
Fan E, O'Neal CJ, Mitchell DD, Robien MA, Zhang Z, Pickens JC, Tan XJ, Korotkov K, Roach C, Krumm B, Verlinde CL, Merritt EA, Hol WG. Fan E, et al. Int J Med Microbiol. 2004 Oct;294(4):217-23. doi: 10.1016/j.ijmm.2004.07.002. Int J Med Microbiol. 2004. PMID: 15532979 Review. - Structural basis for differential receptor binding of cholera and Escherichia coli heat-labile toxins: influence of heterologous amino acid substitutions in the cholera B-subunit.
Bäckström M, Shahabi V, Johansson S, Teneberg S, Kjellberg A, Miller-Podraza H, Holmgren J, Lebens M. Bäckström M, et al. Mol Microbiol. 1997 May;24(3):489-97. doi: 10.1046/j.1365-2958.1997.3541721.x. Mol Microbiol. 1997. PMID: 9179843 - Characterization of the ganglioside recognition profile of Escherichia coli heat-labile enterotoxin LT-IIc.
Zalem D, Juhás M, Terrinoni M, King-Lyons N, Lebens M, Varrot A, Connell TD, Teneberg S. Zalem D, et al. Glycobiology. 2022 Apr 21;32(5):391-403. doi: 10.1093/glycob/cwab133. Glycobiology. 2022. PMID: 34972864 Free PMC article. - Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb.
Fukuta S, Magnani JL, Twiddy EM, Holmes RK, Ginsburg V. Fukuta S, et al. Infect Immun. 1988 Jul;56(7):1748-53. doi: 10.1128/iai.56.7.1748-1753.1988. Infect Immun. 1988. PMID: 3290106 Free PMC article. - Escherichia coli cytotoxins and enterotoxins.
Gyles CL. Gyles CL. Can J Microbiol. 1992 Jul;38(7):734-46. doi: 10.1139/m92-120. Can J Microbiol. 1992. PMID: 1393838 Review.
Cited by
- Effects of Lactobacillus rhamnosus GG supplementation on cow's milk allergy in a mouse model.
Thang CL, Baurhoo B, Boye JI, Simpson BK, Zhao X. Thang CL, et al. Allergy Asthma Clin Immunol. 2011 Dec 6;7(1):20. doi: 10.1186/1710-1492-7-20. Allergy Asthma Clin Immunol. 2011. PMID: 22145744 Free PMC article. - Cholera toxin induces a shift from inactive to active cyclooxygenase 2 in alveolar macrophages activated by Mycobacterium bovis BCG.
Kogiso M, Shinohara T, Dorey CK, Shibata Y. Kogiso M, et al. Infect Immun. 2013 Jan;81(1):373-80. doi: 10.1128/IAI.01031-12. Epub 2012 Nov 12. Infect Immun. 2013. PMID: 23147035 Free PMC article. - The design of new adjuvants for mucosal immunity to Neisseria meningitidis B in nasally primed neonatal mice for adult immune response.
Ferreira T, De Gaspari E. Ferreira T, et al. ScientificWorldJournal. 2012;2012:292073. doi: 10.1100/2012/292073. Epub 2012 Apr 1. ScientificWorldJournal. 2012. PMID: 22545012 Free PMC article. - Recent progress in mucosal vaccine development: potential and limitations.
Lycke N. Lycke N. Nat Rev Immunol. 2012 Jul 25;12(8):592-605. doi: 10.1038/nri3251. Nat Rev Immunol. 2012. PMID: 22828912 Review. - Harnessing Pentameric Scaffold of Cholera Toxin B (CTB) for Design of Subvirion Recombinant Dengue Virus Vaccine.
Sung J, Cheong Y, Kim YS, Ahn J, Sohn MH, Byun S, Seong BL. Sung J, et al. Vaccines (Basel). 2024 Jan 17;12(1):92. doi: 10.3390/vaccines12010092. Vaccines (Basel). 2024. PMID: 38250905 Free PMC article.
References
- Infect Immun. 1992 Feb;60(2):406-15 - PubMed
- J Biol Chem. 1992 Jan 15;267(2):1020-6 - PubMed
- J Biol Chem. 1992 Feb 15;267(5):3230-5 - PubMed
- Nature. 1992 Feb 6;355(6360):561-4 - PubMed
- Nature. 1992 Feb 20;355(6362):748-50 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases